09
Apr

Shire picked up the FDA’s promise of a fast review for its new dry eye drug, a treatment the company believes can eventually bring in more than $1 billion a year.

…read more

Source: Shire’s billion-dollar eye drug gets in line for a speedy FDA review

    

0 No comments